A Single-arm, Phase 2 Study to Evaluate the Safety and Efficacy of IMMU-132 in Patients with MetastaticCastration-Resistant Prostate Cancer Who Have Progressed on Second Generation AR-Directed Therapy

Project: Research project

Project Details

Description

A Single-arm, Phase 2 Study to Evaluate the Safety and Efficacy of IMMU-132 in Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Progressed on Second Generation AR-Directed Therapy
StatusFinished
Effective start/end date12/1/186/30/19

Funding

  • PROSTATE CANCER CLINTRIAL CONSORTIUM LLC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.